NVIDIA launches Jetson Thor robotics computers for physical AI systems
In a recent transaction, Saba Capital Management, L.P., a significant shareholder in abrdn Life Sciences Investors (NASDAQ:HQL), sold 11,419 shares of common stock. The sale, which occurred on May 20, 2025, was executed at a price of $12.71 per share, totaling approximately $145,135. The stock, currently trading at $12.17, offers an impressive 14.19% dividend yield and trades at a P/E ratio of 4, with a market capitalization of $352.17 million. Following this transaction, Saba Capital Management holds 3,017,539 shares indirectly. The filing was signed by Zachary Gindes on behalf of Saba Capital and by Boaz Weinstein, both on May 22, 2025. InvestingPro data reveals that HQL has maintained dividend payments for 30 consecutive years, making it an interesting choice for income-focused investors. Get access to more exclusive insights and analysis with InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.